article thumbnail

Should doctors refuse to treat obese patients?

World of DTC Marketing

This is leading to excessive costs to out healthcare system and something needs to be done. However, despite the momentum the bill has gained throughout the years, the Treat and Reduce Obesity Act (commonly known as TROA) has yet to come up for a committee or floor vote since it was first introduced in 2013.

Doctors 250
article thumbnail

AbbVie announces its new CEO

European Pharmaceutical Review

Richard Gonzalez will retire as the company’s CEO to become Executive Chairman, having served as the company’s CEO since its launch in 2013, AbbVie noted. Richard has facilitated AbbVie securing a market capitalisation increase from $54 billion in 2013 to over $300 billion in 2024.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The current pharma business model is unsustainable

World of DTC Marketing

household income from 2009 to 2013 was $53,046, according to the United States Census Bureau, but many of the most recently approved anticancer treatments approved by the United States Food and Drug Administration (FDA) are priced well above $100,000 per year. .” This leads to a question; “where does it end?”

Pharma 210
article thumbnail

Sorry, the Inflation Bill won’t lower healthcare costs

World of DTC Marketing

This is going to lead to a lot of health problems and associated costs. Congress has taken decisive action to reduce drug prices while ignoring that overall healthcare spending will be a substantial part of GNP. 1ne: A new analysis predicts that by 2030, 48.9% of adults in the United States will be obese, and 24.2% will be severely obese.

article thumbnail

FDA starts review of first drug for alpha-mannosidosis, from Chiesi

pharmaphorum

The vanishingly rare, progressive, and debilitating disease is caused by a deficiency in the enzyme alpha-mannosidase, leading to a build-up of complex sugars that damage the central nervous system and organs of the body. The post FDA starts review of first drug for alpha-mannosidosis, from Chiesi appeared first on.

FDA 105
article thumbnail

Innovative Medicines Fund and the opportunity for ICSs to mobilise NICE approvals

pharmaphorum

Angela spent a decade in pharma sales and marketing management roles with MSD and BMS, prior to staring the world’s second market access agency in 1998, which she sold to IMS Health in 2013. Nina Pinwill leads the commercial operations function within the Commercial Medicines Directorate at NHS England.

Medicine 122
article thumbnail

AbbVie Cork facility €60 million expansion

European Pharmaceutical Review

Construction at the Carrigtwohill facility built in 2013 is set to begin in 2023. to lead R&D organization and drive continued pipeline advancement… The post AbbVie Cork facility €60 million expansion appeared first on European Pharmaceutical Review. AbbVie announces Michael Severino, M.D.